| Literature DB >> 25352216 |
Meekyum Olivia Kim1, Xinxin Feng2, Ferran Feixas3, Wei Zhu2, Steffen Lindert3,4, Shannon Bogue2, William Sinko3, César de Oliveira1,3,4, Guodong Rao2, Eric Oldfield2, James Andrew McCammon1,3,4,5.
Abstract
With the rise in antibiotic resistance, there is interest in discovering new drugs active against new targets. Here, we investigate the dynamic structures of three isoprenoid synthases from Mycobacterium tuberculosis using molecular dynamics (MD) methods with a view to discovering new drug leads. Two of the enzymes, cis-farnesyl diphosphate synthase (cis-FPPS) and cis-decaprenyl diphosphate synthase (cis-DPPS), are involved in bacterial cell wall biosynthesis, while the third, tuberculosinyl adenosine synthase (Rv3378c), is involved in virulence factor formation. The MD results for these three enzymes were then compared with previous results on undecaprenyl diphosphate synthase (UPPS) by means of active site volume fluctuation and principal component analyses. In addition, an analysis of the binding of prenyl diphosphates to cis-FPPS, cis-DPPS, and UPPS utilizing the new MD results is reported. We also screened libraries of inhibitors against cis-DPPS, finding ~1 μm inhibitors, and used the receiver operating characteristic-area under the curve (ROC-AUC) method to test the predictive power of X-ray and MD-derived cis-DPPS receptors. We found that one compound with potent M. tuberculosis cell growth inhibition activity was an IC(50) ~0.5- to 20-μm inhibitor (depending on substrate) of cis-DPPS, a ~660-nm inhibitor of Rv3378c as well as a 4.8-μm inhibitor of cis-FPPS, opening up the possibility of multitarget inhibition involving both cell wall biosynthesis and virulence factor formation.Entities:
Keywords: decaprenyl diphosphate synthase; docking; drug discovery; enzymatic mechanism; farnesyl diphosphate synthase; molecular dynamics; molecular modeling; prenyl synthase; tuberculosinyl adenosine synthase; tuberculosis
Mesh:
Substances:
Year: 2014 PMID: 25352216 PMCID: PMC4412765 DOI: 10.1111/cbdd.12463
Source DB: PubMed Journal: Chem Biol Drug Des ISSN: 1747-0277 Impact factor: 2.817